Literature DB >> 9456115

Controlled reperfusion protects lung grafts during a transient early increase in permeability.

M S Bhabra1, D N Hopkinson, T E Shaw, N Onwu, T L Hooper.   

Abstract

BACKGROUND: We have previously shown that an initial 10-minute period of low-pressure reperfusion prevents the lung graft dysfunction that follows physiologic-pressure reperfusion. Possible mechanisms were investigated in this study.
METHODS: Rat lungs were reperfused ex vivo using a parabiotic animal after 0-hour (groups A through C) or 24-hour (groups D through G) storage. Reperfusion pressure was either physiologic (groups A through D) or reduced by 50% for a specified time (groups E through G). The duration of reperfusion was 5 minutes (groups A, D, and E), 10 minutes (groups B and F), or 30 minutes (groups C and G), at which time endothelial permeability was measured through iodine 125-labeled albumin leakage and neutrophil sequestration through tissue myeloperoxidase activity.
RESULTS: Graft function in group D deteriorated rapidly, whereas groups E through G performed at control levels. Albumin leakage was significantly elevated in group D; with controlled reperfusion, it was elevated after 5 minutes (group E) but had returned to baseline at 10 minutes (group F) and 30 minutes (group G). Myeloperoxidase levels were not significantly different between groups.
CONCLUSIONS: Endothelial permeability is transiently elevated in the early phase of lung graft reperfusion. Initial low-pressure reperfusion may be protective by preventing irreversible edema formation during this period.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9456115     DOI: 10.1016/s0003-4975(97)01002-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  In vitro modeling of nonhypoxic cold ischemia-reperfusion simulating lung transplantation.

Authors:  Monica Casiraghi; Jason R Tatreau; John B Abano; John W Blackwell; Larry Watson; Keith Burridge; Scott H Randell; Thomas M Egan
Journal:  J Thorac Cardiovasc Surg       Date:  2009-09       Impact factor: 5.209

Review 2.  Primary Graft Dysfunction after Lung Transplantation.

Authors:  Gülbin Töre Altun; Mustafa Kemal Arslantaş; İsmail Cinel
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-12-01

3.  Long-term preservation with interim evaluation of lungs from a non-heart-beating donor after a warm ischemic interval of 90 minutes.

Authors:  Filip R Rega; Nicole C Jannis; Geert M Verleden; Toni E Lerut; Dirk E M Van Raemdonck
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

4.  Extracorporeal membrane oxygenation after lung transplantation: risk factors and outcomes analysis.

Authors:  Massimo Boffini; Erika Simonato; Davide Ricci; Fabrizio Scalini; Matteo Marro; Stefano Pidello; Matteo Attisani; Paolo Solidoro; Paolo Olivo Lausi; Vito Fanelli; Cristina Barbero; Luca Brazzi; Mauro Rinaldi
Journal:  Ann Cardiothorac Surg       Date:  2019-01

5.  Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome.

Authors:  Bernhard Moser; Peter Jaksch; Shahrokh Taghavi; Gabriella Muraközy; Georg Lang; Helmut Hager; Claus Krenn; Georg Roth; Peter Faybik; Andreas Bacher; Clemens Aigner; José R Matilla; Konrad Hoetzenecker; Philipp Hacker; Irene Lang; Walter Klepetko
Journal:  Eur J Cardiothorac Surg       Date:  2018-01-01       Impact factor: 4.191

6.  Rat lung transplantation model: modifications of the cuff technique.

Authors:  Dong Tian; Haruhiko Shiiya; Masaaki Sato; Jun Nakajima
Journal:  Ann Transl Med       Date:  2020-03

7.  Length of pressure-controlled reperfusion is critical for reducing ischaemia-reperfusion injury in an isolated rabbit lung model.

Authors:  Stefan Guth; Diethard Prüfer; Thorsten Kramm; Eckhard Mayer
Journal:  J Cardiothorac Surg       Date:  2007-12-07       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.